Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
|Articles|June 1, 2012
Steve Marciniak, RPh, Addresses the Best Practices for Specialty Drug Benefit Management
In this video, Steve Marciniak, RPh, speaks of the challenges and value of specialty drugs.
Advertisement
Steve Marciniak, RPh, Pharmacy Director, Priority Health, states that formulary management, benefit design, distribution channels, and patient care are current best practices used for specialty drug benefit management. He points out the high cost of drugs is one of the prominent challenges in managing the specialty pharmacy benefit.
Advertisement
Related to this article
David G. Mitchell, PharmD, MBA, CSP, FCPhA, of UC Davis Health, explains how AI-assisted prior authorizations have reduced denials and staff time without replacing pharmacist judgment.
Nearly half of working-age adults were inadequately insured in 2026, and half went without needed care due to cost, a Commonwealth Fund survey found.
AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access.
Medicare’s GLP-1 Bridge program aims to expand obesity treatment, but eligibility hurdles and drug costs leave many seniors paying hundreds monthly.
Birth centers are unavailable in 10 states, and 39% of birth center births are self-pay, as licensing and Medicaid pay limit access, a report finds.
At CHEST 2026, 3 speakers explained why respiratory medications stay expensive, assessed what recent federal, state, and industry fixes have achieved, and urged clinicians to use their voices on behalf of patients.
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
3
Uninsured Rate Rises to 11.2% as Coverage Erodes Before Medicaid Cuts
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5